Does the Computed Tomography Hounsfield Units Change Predict Response to Perioperative Chemotherapy in Patients with Gastric Adenocarcinoma

MD, Sener Cihan; MD, Suzan Onol; MD, Selma Sengiz Erhan

doi:10.7150/jca.67734



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2022; 13(5):1449-1455. doi:10.7150/jca.67734 This issue Cite

Research Paper

Does the Computed Tomography Hounsfield Units Change Predict Response to Perioperative Chemotherapy in Patients with Gastric Adenocarcinoma

Sener Cihan MD^1✉, Suzan Onol MD², Selma Sengiz Erhan MD³

1. Department of Medical Oncology, University of Health Sciences, Prof. Dr. Cemil Tascioglu City Hospital, 34384, Istanbul, Turkey.
2. Department of Radiology, University of Health Sciences, Prof. Dr. Cemil Tascioglu City Hospital, 34384, Istanbul, Turkey.
3. Department of Pathology, University of Health Sciences, Prof. Dr. Cemil Tascioglu City Hospital, 34384, Istanbul, Turkey.

Citation:

MD SC, MD SO, MD SSE. Does the Computed Tomography Hounsfield Units Change Predict Response to Perioperative Chemotherapy in Patients with Gastric Adenocarcinoma. J Cancer 2022; 13(5):1449-1455. doi:10.7150/jca.67734. https://www.jcancer.org/v13p1449.htm

Other styles

Abstract

Purpose: We aimed to investigate whether Computed Tomography (CT) attenuation change is predictive of poor pathological response in patients with gastric cancer (GC) and gastroesophageal junction (GEJ) adenocarcinoma who received perioperative fluorouracil (FU), leucovorin (LV), oxaliplatin, and docetaxel (FLOT) regimen.

Methods: This trial was planned as a retrospective single-center study. In the neoadjuvant setting, patients received a regimen that includes docetaxel (50 mg/m²), oxaliplatin (85 mg/m²), and LV (200 mg/m²) with short-term infusional FU (2600 mg/m² as a 24-hour infusion), on day 1 and administered every two weeks for four cycles. Patients were classified as response rates according to the CAP-TRG system (0-1 response or 2-3 response) after completing four cycles of the FLOT regimen.

Results: In total, 108 patients with GC and GEJ adenocarcinoma were included in the study. In a univariate analysis, age, histologic grade, T stage, N stage, and change in attenuation were found to be the statistically significant factors (p = 0.034, p =0.038, p = 0.001, p =0.029, and p = 0.022, respectively). In a multivariate analysis, T4 tumors and a higher change in attenuation were found to be important factors associated with poor pathologic response (p = 0.027 and p = 0.038, respectively).

Conclusion: Our results demonstrate that a higher decrease in CT attenuation and T4 tumors is associated with a poor response to perioperative FLOT chemotherapy in patients with GC and GEJ adenocarcinoma.

Keywords: Adenocarcinoma, Attenuation in computed tomography, Gastric cancer, Pathologic response, Perioperative chemotherapy

Citation styles

APA

MD, S.C., MD, S.O., MD, S.S.E. (2022). Does the Computed Tomography Hounsfield Units Change Predict Response to Perioperative Chemotherapy in Patients with Gastric Adenocarcinoma. Journal of Cancer, 13(5), 1449-1455. https://doi.org/10.7150/jca.67734.

ACS

MD, S.C.; MD, S.O.; MD, S.S.E. Does the Computed Tomography Hounsfield Units Change Predict Response to Perioperative Chemotherapy in Patients with Gastric Adenocarcinoma. J. Cancer 2022, 13 (5), 1449-1455. DOI: 10.7150/jca.67734.

NLM

CSE

MD SC, MD SO, MD SSE. 2022. Does the Computed Tomography Hounsfield Units Change Predict Response to Perioperative Chemotherapy in Patients with Gastric Adenocarcinoma. J Cancer. 13(5):1449-1455.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.